Article
Case Report: Endothelial-targeted bridging therapy for a TTP-like phenotype in fulminant iMCD-TAFRO.
Frontiers in immunology - 1 Jan 2026
Du Jing, Wu Liangliang, Li Haigang, Gan Haibo, Yu Tao, Xie Shuangfeng, Fang Xiangshao
Abstract excerpt
Background: iMCD-TAFRO (the TAFRO clinical subtype of idiopathic multicentric Castleman disease (iMCD)) is characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly. Diagnosis is challenging due to its rarity, non-specific early presentation, and overlap with sepsis, lymphoma, and thrombotic microangiopathy (TMA). Endothelial injury is increasingly recognized as a central driver of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
